science

Edgewise Therapeutics general counsel Moore sells $219,822 in shares

Park Aerospace board chairman & CEO Shore sells $3.05m in stock

Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and compliance with U.S. GMP requirements Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and

Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and compliance with U.S. GMP requirements Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and

Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance

Capricor outlines BLA amendment plan as FDA signals willingness to review, with PDUFA date set for August 22

Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance

Lam Research plans $3B R&D expansion over five years

Pharma companies sour on Swiss drug applications amid Trump’s MFN policy

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,